Regional
Regional Emergency Medical Advisory Committee of New York City
Drugs and doses38
A–C Acetaminophen, Adenosine, Albuterol, Amiodarone, Aspirin, Atropine, Calcium Chloride7
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 15 mg/kg (max 1000 mg) | IV/PO | not captured | standing | page 95 |
| Mild to moderate pain | peds | 15 mg/kg (max 1000 mg) | IV/PO | not captured | standing | page 95 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| SVT | adult | 6 mg | IV | not captured | standing | page 59 |
| SVT | peds | 0.1 mg/kg | IV | not captured | standing | page 59 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 3 mL | NEB | not captured | standing | page 48 |
| Anaphylaxis | peds | 3 mL | NEB | not captured | standing | page 48 |
| Asthma / bronchospasm | adult | 3 mL | NEB | not captured | standing | page 71 |
| Asthma / bronchospasm | peds | 3 mL | NEB | not captured | standing | page 71 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 150 mg | IV | not captured | standing | page 57 |
| Other | adult | 150 mg | IV | not captured | standing | page 60 |
| VF / pulseless VT | adult | 300 mg | IV | not captured | standing | page 35 |
| VF / pulseless VT | peds | 5 mg/kg | IV | not captured | standing | page 35 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | page 54 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV | not captured | standing | page 58 |
| Bradycardia | peds | 0.02 mg/kg | IV | not captured | standing | page 39 |
| Nerve agent exposure | peds | 0.5 mg | IM | not captured | standing | page 121 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 1 g | IV | not captured | standing | page 36 |
| Hyperkalemia | peds | 20 mg/kg | IV | not captured | standing | page 36 |
D–F Dexamethasone, Dextrose, Diazepam, Diltiazem, Diphenhydramine, Dopamine, Epinephrine, Etomidate, Fentanyl, Furosemide10
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.6 mg/kg | IV/IM/PO | not captured | standing | page 49 |
| Anaphylaxis | peds | 0.6 mg/kg | IV/IM/PO | not captured | standing | page 49 |
| Asthma / bronchospasm | adult | 0.6 mg/kg | IV/IM/PO | not captured | standing | page 72 |
| Asthma / bronchospasm | peds | 0.6 mg/kg | IV/IM/PO | not captured | standing | page 72 |
| Croup | adult | 0.6 mg/kg | IV/IM/PO | not captured | standing | page 74 |
| Croup | peds | 0.6 mg/kg | IV/IM/PO | not captured | standing | page 74 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | peds | 0.5 g/kg | IV | not captured | standing | page 37 |
| Neonatal resuscitation | peds | 0.5 g/kg | IV | not captured | standing | page 69 |
| Other | adult | 25 g | IV | not captured | standing | page 46 |
| Other | peds | 0.5 g/kg | IV | not captured | standing | page 46 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperactive delirium | adult | 0.2 mg/kg | IV/IM/IN | not captured | standing | page 52 |
| Nerve agent exposure | peds | 0.5 mg/kg | IM | not captured | standing | page 123 |
| Other | adult | 0.2 mg/kg | IV | not captured | standing | page 98 |
| Procedural sedation | adult | 0.1 mg/kg | IV | not captured | standing | page 98 |
| Seizure | adult | 0.2 mg/kg | IV | not captured | standing | page 84 |
| Seizure | peds | 0.2 mg/kg | IV | not captured | standing | page 84 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 0.25 mg/kg | IV | not captured | standing | page 57 |
| Narrow-complex tachycardia | adult | 0.25 mg/kg | IV | not captured | standing | page 59 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 1 mg/kg | IV/IM | not captured | standing | page 49 |
| Anaphylaxis | peds | 1 mg/kg | IV/IM | not captured | standing | page 49 |
| Dystonic reaction | adult | 1 mg/kg | IV/IM | not captured | standing | page 82 |
| Dystonic reaction | peds | 1 mg/kg | IV/IM | not captured | standing | page 82 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 5 mcg/kg | IV | not captured | standing | page 58 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3 mg | IM | not captured | standing | page 48 |
| Anaphylaxis | peds | 0.15 mg | IM | not captured | standing | page 48 |
| Bradycardia | peds | 0.01 mg/kg | IV | not captured | standing | page 39 |
| Cardiac arrest | adult | 1 mg | IV | not captured | standing | page 35 |
| Cardiac arrest | peds | 0.01 mg/kg | IV | not captured | standing | page 35 |
| Hypotension / shock | adult | 10 mcg | IV | not captured | standing | page 87 |
| Hypotension / shock | peds | 5 mcg | IV | not captured | standing | page 87 |
| Respiratory distress | peds | 0.01 mg/kg | IM | not captured | standing | page 72 |
| Stridor | peds | 3 mg | NEB | not captured | standing | page 74 |
| Stridor | peds | 3 mg | NEB | not captured | standing | page 74 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.3 mg/kg (max 40 mg) | IV | not captured | standing | page 98 |
| Procedural sedation | adult | 0.15 mg/kg (max 20 mg) | IV | not captured | standing | page 98 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mcg/kg (max 100 mcg) | IV | not captured | standing | page 98 |
| Mild to moderate pain | adult | 1 mcg/kg (max 100 mcg) | IV/IM/IN | not captured | standing | page 95 |
| Mild to moderate pain | peds | 1 mcg/kg (max 100 mcg) | IV/IM/IN | not captured | standing | page 95 |
Furosemide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Respiratory distress | adult | 20–80 mg | IV | not captured | standing | page 42 |
G–L Glucagon, Hydroxocobalamin, Ipratropium, Ketamine, Ketorolac, Lidocaine, Lorazepam7
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mg | IM/IN | not captured | standing | page 46 |
| Other | peds | 1 mg | IM/IN | not captured | standing | page 46 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5 g | IV | not captured | standing | page 119 |
| Cyanide poisoning | peds | 75 mg/kg | IV | not captured | standing | page 119 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 2.5 mL | NEB | not captured | standing | page 48 |
| Anaphylaxis | peds | 2.5 mL | NEB | not captured | standing | page 48 |
| Asthma / bronchospasm | adult | 2.5 mL | NEB | not captured | standing | page 71 |
| Asthma / bronchospasm | peds | 2.5 mL | NEB | not captured | standing | page 71 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperactive delirium | adult | 2–4 mg/kg | IM | not captured | standing | page 52 |
| Hyperactive delirium | peds | 1–2 mg/kg | IN | not captured | standing | page 52 |
| Hyperactive delirium | peds | 2–4 mg/kg | IM | not captured | standing | page 52 |
| Other | adult | 1 mg/kg | IV | not captured | standing | page 98 |
| Other | adult | 2 mg/kg | IV | not captured | standing | page 98 |
| Mild to moderate pain | adult | 0.2 mg/kg | IV | not captured | standing | page 96 |
| Mild to moderate pain | adult | 0.4 mg/kg | IM/IN | not captured | standing | page 96 |
| Mild to moderate pain | peds | 0.2 mg/kg | IV | not captured | standing | page 96 |
| Mild to moderate pain | peds | 0.4 mg/kg | IM/IN | not captured | standing | page 96 |
| Procedural sedation | adult | 1 mg/kg | IV | not captured | standing | page 98 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 15 mg | IV/IM | not captured | standing | page 95 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 0.5 mg/kg | IO | not captured | standing | page 19 |
| Mild to moderate pain | peds | 0.5 mg/kg | IO | not captured | standing | page 19 |
| Wide-complex tachycardia | adult | 1 mg/kg | IV | not captured | standing | page 60 |
| VF / pulseless VT | adult | 100 mg | IV | not captured | standing | page 35 |
| VF / pulseless VT | peds | 1 mg/kg | IV | not captured | standing | page 35 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperactive delirium | adult | 0.1 mg/kg | IM | not captured | standing | page 52 |
| Hyperactive delirium | adult | 0.1 mg/kg | IV/IN | not captured | standing | page 52 |
| Hyperactive delirium | peds | 0.1 mg/kg | IM | not captured | standing | page 52 |
| Hyperactive delirium | peds | 0.1 mg/kg | IV/IN | not captured | standing | page 52 |
| Other | adult | 0.1 mg/kg | IV | not captured | standing | page 98 |
| Procedural sedation | adult | 0.02 mg/kg | IV | not captured | standing | page 98 |
| Seizure | adult | 0.1 mg/kg | IV/IM/IN | not captured | standing | page 84 |
| Seizure | peds | 0.1 mg/kg | IV/IM/IN | not captured | standing | page 84 |
M–O Magnesium Sulfate, Methylprednisolone, Metoprolol, Midazolam, Morphine, Naak, Naloxone, Nitroglycerin, Norepinephrine, Ondansetron10
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV | not captured | standing | page 72 |
| Asthma / bronchospasm | peds | 50 mg/kg | IV | not captured | standing | page 72 |
| Eclampsia / pre-eclampsia | adult | 4 g | IV | not captured | standing | page 63 |
| Wide-complex tachycardia | adult | 2 g | IV | not captured | standing | page 60 |
| VF / pulseless VT | adult | 2 g | IV | not captured | standing | page 36 |
| VF / pulseless VT | peds | 25–50 mg/kg | IV | not captured | standing | page 36 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 1 mg/kg | IV/IM | not captured | standing | page 49 |
| Anaphylaxis | peds | 1 mg/kg | IV/IM | not captured | standing | page 49 |
| Asthma / bronchospasm | adult | 1 mg/kg | IV/IM | not captured | standing | page 72 |
| Asthma / bronchospasm | peds | 1 mg/kg | IV/IM | not captured | standing | page 72 |
| Croup | peds | 1 mg/kg | IV/IM | not captured | standing | page 74 |
Metoprolol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Stroke | adult | 5 mg | IV | not captured | standing | page 90 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperactive delirium | adult | 0.2 mg/kg | IM/IN | not captured | standing | page 51 |
| Hyperactive delirium | adult | 0.2 mg/kg | IV | not captured | standing | page 51 |
| Hyperactive delirium | peds | 0.1 mg/kg | IM/IN | not captured | standing | page 51 |
| Hyperactive delirium | peds | 0.1 mg/kg | IV | not captured | standing | page 51 |
| Nerve agent exposure | peds | 0.2 mg/kg | IM | not captured | standing | page 123 |
| Other | adult | 0.2 mg/kg | IV | not captured | standing | page 98 |
| Procedural sedation | adult | 0.1 mg/kg | IV | not captured | standing | page 98 |
| Seizure | adult | 0.2 mg/kg | IV/IM/IN | not captured | standing | page 84 |
| Seizure | peds | 0.2 mg/kg | IV/IM/IN | not captured | standing | page 84 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 0.1 mg/kg (max 5 mg) | IV/IM | not captured | standing | page 95 |
| Mild to moderate pain | peds | 0.1 mg/kg (max 5 mg) | IV/IM | not captured | standing | page 95 |
Naak
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nerve agent exposure | adult | 3 unit | IM | not captured | standing | page 121 |
| Nerve agent exposure | peds | 1–2 unit | IM | not captured | standing | page 121 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 1 mg | IN | not captured | standing | page 81 |
| Opioid overdose | adult | 0.5 mg | IV/IM/IN | not captured | standing | page 82 |
| Opioid overdose | peds | 0.5 mg | IN | not captured | standing | page 81 |
| Opioid overdose | peds | 0.5 mg | IV/IM/IN | not captured | standing | page 82 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 54 |
| CHF / pulmonary edema | adult | 0.4 mg | IV/SL | not captured | standing | page 42 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 2 mcg | IV | not captured | standing | page 87 |
| Hypotension / shock | peds | 0.05 mcg/kg | IV | not captured | standing | page 87 |
| Sepsis | adult | 2 mcg | IV | not captured | standing | page 87 |
| Sepsis | peds | 0.05 mcg/kg | IV | not captured | standing | page 87 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 0.1 mg/kg (max 8 mg) | IV/IM/PO | not captured | standing | page 92 |
| Nausea / vomiting | peds | 0.1 mg/kg (max 8 mg) | IV/IM/PO | not captured | standing | page 92 |
P–R Racemic Epinephrine1
Racemic Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Stridor | peds | 0.5 mL | NEB | not captured | standing | page 74 |
S–Z Sodium Bicarbonate, Sodium Thiosulfate, Vasopressin3
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 44–88 mEq | IV | not captured | standing | page 58 |
| Hyperkalemia | adult | 44–88 mEq | IV | not captured | standing | page 36 |
| Hyperkalemia | peds | 1 mEq/kg | IV | not captured | standing | page 36 |
| Wide-complex tachycardia | adult | 44–88 mEq | IV | not captured | standing | page 60 |
Sodium Thiosulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 12.5 g | IV | not captured | standing | page 119 |
| Cyanide poisoning | peds | 250 mg/kg | IV | not captured | standing | page 119 |
Vasopressin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 0.02 unit | IV | not captured | standing | page 88 |
| Sepsis | adult | 0.02 unit | IV | not captured | standing | page 87 |
Cite this
Regional Emergency Medical Advisory Committee of New York City, United States EMS Protocol Census. 135 dose entries, effective 2026-08-01.
https://protoquiz.com/census/agencies/regional-emergency-medical-advisory-committee-of-new-york-city/
The census is free and not for sale. Only public agencies are named.